Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two Polish NICUs

• Published in: Annals of clinical microbiology and antimicrobials Vol. 12; no. 1; p. 41
• Main Authors: Brzychczy-Wloch, Monika, Borszewska-Kornacka, Maria, Gulczynska, Ewa, Wojkowska-Mach, Jadwiga, Sulik, Malgorzata, Grzebyk, Monika, Luchter, Malgorzata, Heczko, Piotr B, Bulanda, Malgorzata
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 20.12.2013; BioMed Central
• Subjects: Aminoglycosides; Anti-Bacterial Agents - pharmacology; Antibiotics; Biofilms; Complications and side effects; Dosage and administration; Drug resistance; Drug Resistance, Multiple, Bacterial; Drug therapy; Epidemiology; Genes; Genes, Bacterial; Health aspects; Hospitalization; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infants (Newborn); Intensive care; Intensive Care Units, Neonatal; Medical equipment; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Nosocomial infections; Ofloxacin; Physiological apparatus; Poland; Prevalence; Prognosis; Risk factors; Staphylococcal infections; Staphylococcal Infections - epidemiology; Staphylococcal Infections - microbiology; Staphylococcus - classification; Staphylococcus - drug effects; Staphylococcus - genetics; Staphylococcus - isolation & purification; Studies; Poland
• ISSN: 1476-0711; 1476-0711
• DOI: 10.1186/1476-0711-12-41

Multi-drug resistant coagulaso-negative staphylococci (CNS) have become an increasing problem in nosocomial infections connected with the presence of medical devices. The paper aimed to analyze the prevalence of antibiotic resistance in CNS isolated from invasive infection in very low birth weight (VLBW) neonates. Continuous prospective target surveillance of infections was conducted in 2009 at two Polish NICUs that participated in the Polish Neonatology Surveillance Network (PNSN). The study covered 386 neonates with VLBW (≤1500 g), among which 262 cases of invasive infection were detected with predominance of CNS (123; 47%). Altogether, 100 CNS strains were analyzed. The resistance phenotypes were determined according to EUCAST. Resistance genes: mecA, ermA, ermB, ermC, msrA, aac(6')/aph(2''), ant(4')-Ia and aph(3')-IIIa were detected using multiplex PCR. The most common species was S. epidermidis (63%), then S. haemolyticus (28%) and other CNS (9%). Among S. epidermidis, 98% of isolates were resistant to methicillin, 90% to erythromycin, 39% to clindamycin, 95% to gentamicin, 60% to amikacin, 36% to ofloxacin, 2% to tigecycline, 3% to linezolid and 13% to teicoplanin. Among S. haemolyticus isolates, 100% were resistant to methicillin, erythromycin and gentamicin, 18% to clindamycin, 50% to amikacin, 86% to ofloxacin, 14% to tigecycline and 4% to teicoplanin. No resistance to linezolid was detected for S. haemolyticus isolates. Moreover, all isolates of S. epidermidis and S. haemolyticus were susceptible to vancomycin. The mecA gene was detected in 98% of S. epidermidis isolates and all of S. haemolyticus ones. Among macrolide resistance isolates, the ermC was most common in S. epidermidis (60%) while msrA was prevalent in S. haemolyticus (93%). The ermC gene was indicated in all isolates with cMLSB, whereas mrsA was found in isolates with MSB phenotype. Of the aminoglycoside resistance genes, aac(6')/aph(2'') were present alone in 83% of S. epidermidis, whereas aac(6')/aph(2'') with aph(3')-IIIa were predominant in 84% of S. haemolyticus. Knowing the epidemiology and antibiotic resistance of CNS isolated from invasive infection in VLBW neonates is a key step in developing targeted prevention strategies and reducing antibiotic consumption.